Effect of multiple micronutrient supplementation during pregnancy on maternal and birth outcomes
Citation: Haider B.A., Yakoob M.Y., & Bhutta Z.A. Effect of multiple micronutrient supplementation during pregnancy on maternal and birth outcomes. BMC Public Health, 2011;11(3):1-9
This review provides evidence of a significant benefit of multiple micronutrient (MMN) supplementation during pregnancy on reducing small-for-gestational age (SGA) births as compared to iron-folate, with no significant increase in the risk of neonatal mortality in populations where skilled birth care is available and majority of births take place in facilities.
Micronutrient deficiency is prevalent in developing countries, especially in the cases of mothers and infants. This review aimed to assess MMN supplementation during pregnancy in comparison to iron-folate alone, in improving maternal complications, SGA births, low birth weight, stillbirths, perinatal and neonatal mortality. Seventeen studies were included in this review and were assessed for quality and data abstraction. Results showed a significant reduction in SGA using MMN supplementation compared to iron-folate. No significant benefit was found for maternal anemia. Overall there was no increase in the risk of neonatal mortality from using MMN over iron-folate.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence the prevention and treatment of malnutrition but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about prevention or treatment of malnutirition on the basis of this summary alone.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.